Related Experiment Video
Updated: Mar 21, 2026

The Establishment of a Lung Colonization Assay for Circulating Tumor Cell Visualization in Lung Tissues
Published on: June 16, 2018
RIG-like Helicase Regulation of Chitinase 3-like 1 Axis and Pulmonary Metastasis
Bing Ma1, Erica L Herzog2, Meagan Moore2
1Department of Molecular Microbiology and Immunology, Brown University, Providence, R.I. 02912, USA.
Abstract:
Chi3l1 is induced by a variety of cancers where it portends a poor prognosis and plays a key role in the generation of metastasis. However, the mechanisms that Chi3l1 uses to mediate these responses and the pathways that control Chi3l1-induced tumor responses are poorly understood. We characterized the mechanisms that Chi3l1 uses to foster tumor progression and the ability of the RIG-like helicase (RLH) innate immune response to control Chi3l1 elaboration and pulmonary metastasis. Here we demonstrate that RLH activation inhibits tumor induction of Chi3l1 and the expression of receptor IL-13Rα2 and pulmonary metastasis while restoring NK cell accumulation and activation, augmenting the expression of IFN-α/β, chemerin and its receptor ChemR23, p-cofilin, LIMK2 and PTEN and inhibiting BRAF and NLRX1 in a MAVS-dependent manner. These studies demonstrate that Chi3l1 is a multifaceted immune stimulator of tumor progression and metastasis whose elaboration and tissue effects are abrogated by RLH innate immune responses.
Insights
The RIG-like helicase (RLH) innate immune response inhibits cancer-promoting Chi3l1 and metastasis. RLH activation abrogates Chi3l1
Area of Science:
- Immunology
- Oncology
- Molecular Biology
Background:
- Chitinase 3-like 1 (Chi3l1) is linked to poor cancer prognosis and metastasis.
- Mechanisms of Chi3l1 in tumor progression and its regulatory pathways are not fully understood.
Purpose of the Study:
- To investigate how Chi3l1 promotes tumor progression and metastasis.
- To determine if the RIG-like helicase (RLH) innate immune response can control Chi3l1 and metastasis.
Main Methods:
- Characterization of Chi3l1-mediated tumor progression mechanisms.
- Assessment of RLH activation's effect on Chi3l1, metastasis, and immune responses.
- MAVS-dependent pathway analysis.
Main Results:
- RLH activation suppressed tumor-induced Chi3l1 and IL-13Rα2 expression, inhibiting pulmonary metastasis.
- RLH restored NK cell activity, increased IFN-α/β, chemerin/ChemR23, p-cofilin, LIMK2, and PTEN.
- RLH inhibited BRAF and NLRX1 expression in a MAVS-dependent manner.
Conclusions:
- Chi3l1 acts as a multifaceted immune stimulator promoting tumor progression and metastasis.
- RLH innate immune responses effectively abrogate Chi3l1's tumor-promoting effects and metastasis.
More Related Videos
Related Concept Videos
Mechanism of Filopodia Formation
Their main function is to guide migrating cells during normal tissue morphogenesis or cancer metastasis by recognizing and making initial contacts with the extracellular matrix. However, they can also act as stationary cell anchors or help to establish communication...
Mechanism of Lamellipodia Formation
Regulation of Angiogenesis and Blood Supply
Cancer Cell Migration through Invadopodia
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Hedgehog Signaling Pathway

